Diabetes Drug Gets FDA Warning Due to Amputation Risk0 0August 7, 2018UncategorizedThe type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration [...]